Lan Hong1, Xin Cheng1, Longting Lin2, Andrew Bivard3, Yifeng Ling1, Kenneth Butcher4, Qiang Dong1, Mark Parsons3. 1. Department of Neurology, National Clinical Research Center for Aging and Medicine, Huashan Hospital, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China. 2. School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia. 3. Department of Neurology, Royal Melbourne Hospital, Melbourne Brain Centre, University of Melbourne, Melbourne, Victoria, Australia. 4. Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Abstract
OBJECTIVE: To explore the association of poststroke baseline blood pressure with cerebral collateral flow and functional outcome in acute ischemic patients with large vessel occlusion/stenosis. METHODS: Patients identified with large vessel occlusion/stenosis with baseline multimodal computed tomography, follow-up imaging, and complete clinical profiles were included. A 90-day modified Rankin Scale of 0-1 was defined as an excellent functional outcome. Cerebral collateral flow was quantified by the volume ratio of tissue within the delay time >3 seconds perfusion lesion with severely delayed contrast transit (delay time >3 seconds/delay time >6 seconds). RESULTS: There were 306 patients included in this study. With every increase of 10 mmHg in baseline systolic blood pressure, the odds of achieving an excellent functional outcome decreased by 12% in multivariate analysis (odds ratio = 0.88, p = 0.048). Conversely, increased baseline blood pressure was associated with better collateral flow. In subgroup analysis of patients with major reperfusion, higher blood pressure was associated with decreased infarct growth and a better clinical outcome, and vice versa in patients without reperfusion. INTERPRETATION: Higher baseline blood pressure in acute ischemic stroke patients with large vessel occlusion/stenosis was associated with better collateral flow. However, for patients without reperfusion, higher baseline blood pressure was associated with increased infarct growth, leading to an unfavorable clinical outcome. The relationship between blood pressure and outcomes is highly dependent on reperfusion, and active blood pressure-lowering treatment may be inappropriate in acute ischemic stroke patients prior to reperfusion treatment. ANN NEUROL 2019;85:331-339.
OBJECTIVE: To explore the association of poststroke baseline blood pressure with cerebral collateral flow and functional outcome in acute ischemicpatients with large vessel occlusion/stenosis. METHODS:Patients identified with large vessel occlusion/stenosis with baseline multimodal computed tomography, follow-up imaging, and complete clinical profiles were included. A 90-day modified Rankin Scale of 0-1 was defined as an excellent functional outcome. Cerebral collateral flow was quantified by the volume ratio of tissue within the delay time >3 seconds perfusion lesion with severely delayed contrast transit (delay time >3 seconds/delay time >6 seconds). RESULTS: There were 306 patients included in this study. With every increase of 10 mmHg in baseline systolic blood pressure, the odds of achieving an excellent functional outcome decreased by 12% in multivariate analysis (odds ratio = 0.88, p = 0.048). Conversely, increased baseline blood pressure was associated with better collateral flow. In subgroup analysis of patients with major reperfusion, higher blood pressure was associated with decreased infarct growth and a better clinical outcome, and vice versa in patients without reperfusion. INTERPRETATION: Higher baseline blood pressure in acute ischemic strokepatients with large vessel occlusion/stenosis was associated with better collateral flow. However, for patients without reperfusion, higher baseline blood pressure was associated with increased infarct growth, leading to an unfavorable clinical outcome. The relationship between blood pressure and outcomes is highly dependent on reperfusion, and active blood pressure-lowering treatment may be inappropriate in acute ischemic strokepatients prior to reperfusion treatment. ANN NEUROL 2019;85:331-339.
Authors: Nils H Petersen; Sreeja Kodali; Can Meng; Fangyong Li; Cindy Khanh Nguyen; Krithika U Peshwe; Sumita Strander; Andrew Silverman; Alexandra Kimmel; Anson Wang; Mohammad Anadani; Eyad Almallouhi; Alejandro M Spiotta; Joon-Tae Kim; James A Giles; Salah G Keyrouz; Mudassir Farooqui; Cynthia Zevallos; Ilko L Maier; Marios-Nikos Psychogios; Jan Liman; Nolwenn Riou-Comte; Sébastien Richard; Benjamin Gory; Stacey Quintero Wolfe; Patrick A Brown; Kyle M Fargen; Eva A Mistry; Hiba Fakhri; Akshitkumar M Mistry; Ka-Ho Wong; Adam de Havenon; Fábio A Nascimento; Peter Kan; Charles Matouk; Santiago Ortega-Gutiérrez; Kevin N Sheth Journal: Stroke Date: 2021-11-16 Impact factor: 7.914
Authors: Nerea Arrarte Terreros; Bettine G van Willigen; Wera S Niekolaas; Manon L Tolhuisen; Josje Brouwer; Jonathan M Coutinho; Ludo Fm Beenen; Charles Blm Majoie; Ed van Bavel; Henk A Marquering Journal: J Cereb Blood Flow Metab Date: 2021-09-22 Impact factor: 6.960
Authors: Sophie A van den Berg; Simone M Uniken Venema; Maxim J H L Mulder; Kilian M Treurniet; Noor Samuels; Hester F Lingsma; Robert-Jan B Goldhoorn; Ivo G H Jansen; Jonathan M Coutinho; Bob Roozenbeek; Diederik W J Dippel; Yvo B W E M Roos; H Bart van der Worp; Paul J Nederkoorn Journal: Stroke Date: 2020-10-12 Impact factor: 7.914
Authors: Bogna A Drozdowska; Emma Elliott; Martin Taylor-Rowan; Robert C Shaw; Gillian Cuthbertson; Peter Langhorne; Terence J Quinn Journal: Alzheimers Res Ther Date: 2020-07-16 Impact factor: 6.982